Last reviewed · How we verify
NCT03653572
Clinical Evaluation of the Next Generation Venue Ultrasound System, Components, and Accessories - Canada
NA trial testing Ultrasound exam in Ultrasound Use in Emergency/Medical Care in 35 participants. Completed in 2 August 2017.
1 August 2017
Quick facts
| Lead sponsor | GE Healthcare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 35 |
| Start date | 14 June 2017 |
| Primary completion | 1 August 2017 |
| Estimated completion | 2 August 2017 |
| Sites | 1 location across Canada |
Drugs / interventions tested
- Ultrasound exam
Conditions studied
- Ultrasound Use in Emergency/Medical Care — all drugs for Ultrasound Use in Emergency/Medical Care →
Sponsor
GE Healthcare — full company profile →
Who can join
18 and older, any sex, with Ultrasound Use in Emergency/Medical Care. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to collect images data sets from clinical cases and periodic user feedback on the Next Generation Venue ultrasound system under clinical conditions. This is a medical device study designed as a clinical, open label, unblinded, non-randomized, prospective, feasibility research study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03653572
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Ultrasound exam
Trials testing the same drug.
- NCT06525831 — Rein 3D PRINT MECHANICS · NA · recruiting
- NCT05389553 — Fetal Doppler and Uterine Artery Blood Volume Correlation. · completed
- NCT05204771 — Prenatal US Assessment of Superior Mesenteric Vessels for Digestive Rotation · completed
- NCT05148429 — Prenatal Screening of Intestinal Malrotation With a Higher Risk of Volvulus. · completed
Other GE Healthcare trials
Trials by the same sponsor.
- NCT07472491 — A Phase 2/3 Study on the Efficacy and Safety of Mangaciclanol for Contrast-Enhanced MRI of CNS or Body in Adult Patients · Phase 2, PHASE3 · recruiting
- NCT07394140 — NMT EasyFit Sensor and Cable · NA · not yet recruiting
- NCT07024472 — NIBP Cuff Comparison Study · completed
- NCT06835647 — Maternal Fetal Device Performance Twins · NA · recruiting
- NCT06639828 — Phase 4 Paediatric Study to Evaluate Sonazoid Safety and Efficacy for Contrast-Enhanced Ultrasound Liver Imaging · Phase 4 · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03653572 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by GE Healthcare
- Last refreshed: 31 August 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03653572.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing